Jang-Won Park Selected Research

Aluminum Oxide (Sapphire)

7/2020	Eighteen-Year Results of Cementless THA with Alumina-on-HXLPE Bearings in Patients <30 Years Old: A Concise Follow-up of a Previous Report.
1/2017	Alumina Delta-on-Alumina Delta Bearing in Cementless Total Hip Arthroplasty in Patients Aged <50 Years.
12/2016	Alumina Delta-on-Highly Crosslinked-Remelted Polyethylene Bearing in Cementless Total Hip Arthroplasty in Patients Younger than 50 Years.
11/2016	Long-Term Results of Third-Generation Ceramic-on-Ceramic Bearing Cementless Total Hip Arthroplasty in Young Patients.
10/2016	Alumina Delta-on-Alumina Delta Bearing in Cementless Total Hip Arthroplasty in Patients Aged <50 Years.
11/2013	A randomised prospective evaluation of ceramic-on-ceramic and ceramic-on-highly cross-linked polyethylene bearings in the same patients with primary cementless total hip arthroplasty.
6/2013	Polyethylene wear and osteolysis after cementless total hip arthroplasty with alumina-on-highly cross-linked polyethylene bearings in patients younger than thirty years of age.
9/2012	Cementless metaphyseal fitting anatomic total hip arthroplasty with a ceramic-on-ceramic bearing in patients thirty years of age or younger.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jang-Won Park Research Topics

Disease

17	Osteolysis 09/2020 - 01/2012
5	Osteoarthritis 01/2021 - 08/2012
5	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 04/2015
5	Pain (Aches) 06/2017 - 10/2011
4	Infections 01/2022 - 02/2014
3	Pulmonary Embolism 01/2017 - 04/2015
2	Osteonecrosis (Kienbock's Disease) 01/2020 - 10/2011
2	Thromboembolism 01/2018 - 01/2017
1	Sepsis (Septicemia) 01/2022
1	Neoplasms (Cancer) 12/2021
1	Reinfection 01/2021
1	Postoperative Hemorrhage 01/2017
1	Periprosthetic Fractures 02/2014

Drug/Important Bio-Agent (IBA)

11	Polyethylene (Polythene)IBA 09/2020 - 06/2013
8	Aluminum Oxide (Sapphire)IBA 07/2020 - 09/2012
3	Tranexamic Acid (AMCA)FDA Link 11/2018 - 01/2017
2	3,5-tetrahydroaldosterone sulfate (THAS)IBA 09/2016 - 01/2012
1	IntegrinsIBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 09/2016

Therapy/Procedure

13	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022 - 10/2011
6	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 08/2012
5	Arthroplasty 01/2021 - 02/2014
3	Prostheses and Implants (Prosthesis) 01/2021 - 08/2012
2	Knee Prosthesis 10/2017 - 11/2014
1	Hip Prosthesis 09/2012
1	Intra-Articular Injections 10/2011